Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

How artificial intelligence is changing nursing.

Robert N.

Nurs Manage. 2019 Aug 14. doi: 10.1097/01.NUMA.0000578988.56622.21. [Epub ahead of print] No abstract available.

PMID:
31425440
2.

Ancient animal genome architecture reflects cell type identities.

Zimmermann B, Robert NSM, Technau U, Simakov O.

Nat Ecol Evol. 2019 Aug 5. doi: 10.1038/s41559-019-0946-7. [Epub ahead of print]

PMID:
31383947
3.

Determination of 3D PSFs from computed tomography reconstructed x-ray images of spherical objects and the effects of sphere radii.

Robert N, Mainprize JG, Whyne C.

Med Phys. 2019 Aug 5. doi: 10.1002/mp.13734. [Epub ahead of print]

PMID:
31381159
4.

Kinome expression profiling to target new therapeutic avenues in multiple myeloma.

de Boussac H, Bruyer A, Jourdan M, Maes A, Robert N, Gourzones C, Vincent L, Seckinger A, Cartron G, Hose D, De Bruyne E, Kassambara A, Pasero P, Moreaux J.

Haematologica. 2019 Jul 9. pii: haematol.2018.208306. doi: 10.3324/haematol.2018.208306. [Epub ahead of print]

5.

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation.

Chatonnet F, Pignarre A, Sérandour AA, Caron G, Avner S, Robert N, Kassambara A, Laurent A, Bizot M, Agirre X, Prosper F, Martin-Subero JI, Moreaux J, Fest T, Salbert G.

Haematologica. 2019 Jun 20. pii: haematol.2019.222133. doi: 10.3324/haematol.2019.222133. [Epub ahead of print]

6.

Assessment of prevalence of attention deficit hyperactivity disorder among schoolchildren in selected schools.

Catherine TG, Robert NG, Mala KK, Kanniammal C, Arullapan J.

Indian J Psychiatry. 2019 May-Jun;61(3):232-237. doi: 10.4103/psychiatry.IndianJPsychiatry_333_17.

7.

Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.

Flannery K, Boyd M, Black-Shinn J, Robert N, Kamat AM.

Future Oncol. 2019 Apr;15(12):1323-1334. doi: 10.2217/fon-2018-0654. Epub 2019 Apr 3.

PMID:
30942088
8.

Treatment According to a Comprehensive Molecular Profiling Can Lead to a Better Outcome in Heavily Pretreated Patients With Metastatic Cancer: Data of a Pooled Analysis.

Seeber A, Chahine G, Nasr F, Dean A, Miranova M, Jameson G, Robert N, Gastl G, Zwierzina H.

Cancer J. 2019 Mar/Apr;25(2):73-79. doi: 10.1097/PPO.0000000000000358.

PMID:
30896526
9.

PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J 2nd, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A.

Breast Cancer Res. 2019 Mar 11;21(1):39. doi: 10.1186/s13058-019-1115-2.

10.

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.

Vikova V, Jourdan M, Robert N, Requirand G, Boireau S, Bruyer A, Vincent L, Cartron G, Klein B, Elemento O, Kassambara A, Moreaux J.

Theranostics. 2019 Jan 1;9(2):540-553. doi: 10.7150/thno.28374. eCollection 2019.

11.

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.

Cortes J, Calvo V, Ramírez-Merino N, O'Shaughnessy J, Brufsky A, Robert N, Vidal M, Muñoz E, Perez J, Dawood S, Saura C, Di Cosimo S, González-Martín A, Bellet M, Silva OE, Miles D, Llombart A, Baselga J.

Ann Oncol. 2019 Jan 9. doi: 10.1093/annonc/mdy535. [Epub ahead of print] No abstract available.

PMID:
30624662
12.

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.

Press MF, Seoane JA, Curtis C, Quinaux E, Guzman R, Sauter G, Eiermann W, Mackey JR, Robert N, Pienkowski T, Crown J, Martin M, Valero V, Bee V, Ma Y, Villalobos I, Slamon DJ.

JAMA Oncol. 2019 Mar 1;5(3):366-375. doi: 10.1001/jamaoncol.2018.6012.

13.

BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.

Requirand G, Robert N, Boireau S, Vincent L, Seckinger A, Bouhya S, Ceballos P, Cartron G, Hose D, Klein B, Moreaux J.

Cytometry B Clin Cytom. 2019 May;96(3):209-214. doi: 10.1002/cyto.b.21730. Epub 2018 Nov 12.

PMID:
30417559
14.

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs.

Herviou L, Kassambara A, Boireau S, Robert N, Requirand G, Müller-Tidow C, Vincent L, Seckinger A, Goldschmidt H, Cartron G, Hose D, Cavalli G, Moreaux J.

Clin Epigenetics. 2018 Oct 3;10(1):121. doi: 10.1186/s13148-018-0554-4.

15.

Evaluation of a one-piece soft convex ostomy appliance: a prospective, multicentre, open-label pilot study.

Rat P, Robert N, Fernandes I, Edmond D, Mauvais F.

Br J Nurs. 2018 Sep 6;27(16):S20-S28. doi: 10.12968/bjon.2018.27.16.S20.

PMID:
30187789
16.

THE LYSOSOMAL STORAGE DISEASE GM2 GANGLIOSIDOSIS IN CAPTIVE BANDED MONGOOSE SIBLINGS ( MUNGOS MUNGO).

Wimmershoff J, Kuehni-Boghenbor K, Sewell AC, Oevermann A, Farwanah H, Robert N, Hoby S, Wenker C, Stoffel MH.

J Zoo Wildl Med. 2018 Jun;49(2):335-344. doi: 10.1638/2017-0199.1.

PMID:
29900785
17.

Factors associated with the growing-finishing performances of swine herds: an exploratory study on serological and herd level indicators.

Fablet C, Rose N, Grasland B, Robert N, Lewandowski E, Gosselin M.

Porcine Health Manag. 2018 Mar 22;4:6. doi: 10.1186/s40813-018-0082-9. eCollection 2018.

18.

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.

Bruyer A, Maes K, Herviou L, Kassambara A, Seckinger A, Cartron G, Rème T, Robert N, Requirand G, Boireau S, Müller-Tidow C, Veyrune JL, Vincent L, Bouhya S, Goldschmidt H, Vanderkerken K, Hose D, Klein B, De Bruyne E, Moreaux J.

Br J Cancer. 2018 Apr;118(8):1062-1073. doi: 10.1038/s41416-018-0025-x. Epub 2018 Mar 2.

19.

Retinoic acid signaling and neurogenic niche regulation in the developing peripheral nervous system of the cephalochordate amphioxus.

Zieger E, Garbarino G, Robert NSM, Yu JK, Croce JC, Candiani S, Schubert M.

Cell Mol Life Sci. 2018 Jul;75(13):2407-2429. doi: 10.1007/s00018-017-2734-3. Epub 2018 Jan 31.

PMID:
29387904
20.

Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.

De Smedt E, Maes K, Verhulst S, Lui H, Kassambara A, Maes A, Robert N, Heirman C, Cakana A, Hose D, Breckpot K, van Grunsven LA, De Veirman K, Menu E, Vanderkerken K, Moreaux J, De Bruyne E.

Cancer Res. 2018 Mar 1;78(5):1155-1168. doi: 10.1158/0008-5472.CAN-17-1544. Epub 2017 Dec 19.

21.

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.

Alaterre E, Raimbault S, Goldschmidt H, Bouhya S, Requirand G, Robert N, Boireau S, Seckinger A, Hose D, Klein B, Moreaux J.

Oncotarget. 2017 Oct 30;8(58):98931-98944. doi: 10.18632/oncotarget.22131. eCollection 2017 Nov 17.

22.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.

Blum JL, Robert N, Andersen J, Favret A, Ward P, Osborne C, Pippen J.

J Clin Oncol. 2018 Feb 1;36(4):428-429. doi: 10.1200/JCO.2017.75.3756. Epub 2017 Dec 11. No abstract available.

PMID:
29227724
23.

Predictors of Program Completion and NCLEX-RN Success in an Associate Degree Nursing Program.

Robert N.

Nurs Educ Perspect. 2018 Jan/Feb;39(1):38-39. doi: 10.1097/01.NEP.0000000000000237.

PMID:
29120934
24.

Epidemiological and clinical assessment of a shared territorial malaria guideline in the 10 years of its implementation (Barcelona, North Metropolitan Area, Catalonia, Spain, 2007-2016).

Mòdol JM, Roure S, Smithson À, Fernández-Rivas G, Esquerrà A, Robert N, Méndez M, Ramos J, Carreres A, Valerio L.

Malar J. 2017 Sep 11;16(1):365. doi: 10.1186/s12936-017-2007-5.

25.

Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.

Robert NJ, Denduluri N.

Clin Breast Cancer. 2018 Jun;18(3):192-204. doi: 10.1016/j.clbc.2017.05.014. Epub 2017 Jun 7. Review.

26.

Characterization of human FCRL4-positive B cells.

Jourdan M, Robert N, Cren M, Thibaut C, Duperray C, Kassambara A, Cogné M, Tarte K, Klein B, Moreaux J.

PLoS One. 2017 Jun 21;12(6):e0179793. doi: 10.1371/journal.pone.0179793. eCollection 2017.

27.

Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.

Kassambara A, Jourdan M, Bruyer A, Robert N, Pantesco V, Elemento O, Klein B, Moreaux J.

Nucleic Acids Res. 2017 Jun 2;45(10):5639-5652. doi: 10.1093/nar/gkx327.

28.

Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.

Pierobon M, Ramos C, Wong S, Hodge KA, Aldrich J, Byron S, Anthony SP, Robert NJ, Northfelt DW, Jahanzeb M, Vocila L, Wulfkuhle J, Gambara G, Gallagher RI, Dunetz B, Hoke N, Dong T, Craig DW, Cristofanilli M, Leyland-Jones B, Liotta LA, O'Shaughnessy JA, Carpten JD, Petricoin EF.

Clin Cancer Res. 2017 Aug 15;23(16):4919-4928. doi: 10.1158/1078-0432.CCR-16-2656. Epub 2017 Apr 26.

29.

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

Blum JL, Flynn PJ, Yothers G, Asmar L, Geyer CE Jr, Jacobs SA, Robert NJ, Hopkins JO, O'Shaughnessy JA, Dang CT, Gómez HL, Fehrenbacher L, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Jeong JH, Colangelo LH, Swain SM, Mamounas EP, Jones SE, Wolmark N.

J Clin Oncol. 2017 Aug 10;35(23):2647-2655. doi: 10.1200/JCO.2016.71.4147. Epub 2017 Apr 11.

30.

FOXA3 Is Expressed in Multiple Cell Lineages in the Mouse Testis and Regulates Pdgfra Expression in Leydig Cells.

Garon G, Bergeron F, Brousseau C, Robert NM, Tremblay JJ.

Endocrinology. 2017 Jun 1;158(6):1886-1897. doi: 10.1210/en.2016-1736.

PMID:
28379539
31.

HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes.

Robert NJ, Goertz HP, Chopra P, Jiao X, Yoo B, Patt D, Antao V.

Drugs Real World Outcomes. 2017 Mar;4(1):1-7. doi: 10.1007/s40801-016-0102-5.

32.

Negative pressure wound therapy in orthopaedic surgery.

Robert N.

Orthop Traumatol Surg Res. 2017 Feb;103(1S):S99-S103. doi: 10.1016/j.otsr.2016.04.018. Epub 2016 Dec 30. Review.

33.

EGR1 Regulates Transcription Downstream of Mechanical Signals during Tendon Formation and Healing.

Gaut L, Robert N, Delalande A, Bonnin MA, Pichon C, Duprez D.

PLoS One. 2016 Nov 7;11(11):e0166237. doi: 10.1371/journal.pone.0166237. eCollection 2016.

34.

A Provably-Secure Transmission Scheme for Wireless Body Area Networks.

Omala AA, Robert N, Li F.

J Med Syst. 2016 Nov;40(11):247. Epub 2016 Oct 4.

PMID:
27704456
35.

NEPHROPATHIES IN THE EUROPEAN CAPTIVE CHEETAH (ACINONYX JUBATUS) POPULATION.

Url A, Krutak V, Kübber-Heiss A, Chvala-Mannsberger S, Robert N, Dinhopl N, Schmidt P, Walzer C.

J Zoo Wildl Med. 2016 Sep;47(3):797-805.

PMID:
27691976
36.

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials.

Press MF, Sauter G, Buyse M, Fourmanoir H, Quinaux E, Tsao-Wei DD, Eiermann W, Robert N, Pienkowski T, Crown J, Martin M, Valero V, Mackey JR, Bee V, Ma Y, Villalobos I, Campeau A, Mirlacher M, Lindsay MA, Slamon DJ.

J Clin Oncol. 2016 Oct 10;34(29):3518-3528. doi: 10.1200/JCO.2016.66.6693.

37.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR.

N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5.

38.

Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense.

Kaur P, Datta S, Shandil RK, Kumar N, Robert N, Sokhi UK, Guptha S, Narayanan S, Anbarasu A, Ramaiah S.

PLoS One. 2016 May 4;11(5):e0154513. doi: 10.1371/journal.pone.0154513. eCollection 2016.

39.

Challenges With Research Contract Negotiations in Community-Based Cancer Research.

Thompson MA, Hurley PA, Faller B, Longinette J, Richter K, Stewart TL, Robert N.

J Oncol Pract. 2016 Jun;12(6):e626-32. doi: 10.1200/JOP.2016.010975. Epub 2016 May 3.

PMID:
27143149
40.

Differential effects of lenalidomide during plasma cell differentiation.

Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, Ceballos P, Cartron G, Rossi JF, Moreaux J, Chopra R, Klein B.

Oncotarget. 2016 May 10;7(19):28096-111. doi: 10.18632/oncotarget.8581.

41.

Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium.

Sanvisens A, Robert N, Hernández JM, Zuluaga P, Farré M, Coroleu W, Serra M, Tor J, Muga R.

Int J Mol Sci. 2016 Mar 22;17(3):417. doi: 10.3390/ijms17030417.

42.

Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool.

Good MJ, Hurley P, Woo KM, Szczepanek C, Stewart T, Robert N, Lyss A, Gönen M, Lilenbaum R.

J Oncol Pract. 2016 May;12(5):e536-47. doi: 10.1200/JOP.2015.008920. Epub 2016 Mar 22.

43.

The impact of raw materials and baking conditions on Maillard reaction products, thiamine, folate, phytic acid and minerals in white bread.

Helou C, Gadonna-Widehem P, Robert N, Branlard G, Thebault J, Librere S, Jacquot S, Mardon J, Piquet-Pissaloux A, Chapron S, Chatillon A, Niquet-Léridon C, Tessier FJ.

Food Funct. 2016 Jun 15;7(6):2498-507. doi: 10.1039/c5fo01341k.

PMID:
26974195
44.

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SK, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J 2nd, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M; ExteNET Study Group.

Lancet Oncol. 2016 Mar;17(3):367-77. doi: 10.1016/S1470-2045(15)00551-3. Epub 2016 Feb 10.

PMID:
26874901
45.

KLF6 cooperates with NUR77 and SF1 to activate the human INSL3 promoter in mouse MA-10 leydig cells.

Tremblay MA, Mendoza-Villarroel RE, Robert NM, Bergeron F, Tremblay JJ.

J Mol Endocrinol. 2016 Apr;56(3):163-73. doi: 10.1530/JME-15-0139. Epub 2016 Feb 12.

PMID:
26874000
46.

Calcium-dependent Nr4a1 expression in mouse Leydig cells requires distinct AP1/CRE and MEF2 elements.

Abdou HS, Robert NM, Tremblay JJ.

J Mol Endocrinol. 2016 Apr;56(3):151-61. doi: 10.1530/JME-15-0202. Epub 2015 Dec 8.

PMID:
26647388
47.

Post-traumatic stress disorder.

Bisson JI, Cosgrove S, Lewis C, Robert NP.

BMJ. 2015 Nov 26;351:h6161. doi: 10.1136/bmj.h6161. Review. No abstract available.

48.

3D localization of electrophysiology catheters from a single x-ray cone-beam projection.

Robert N, Polack GG, Sethi B, Rowlands JA, Crystal E.

Med Phys. 2015 Oct;42(10):6112-24. doi: 10.1118/1.4931452.

PMID:
26429286
49.

Factors Associated with Breastfeeding Initiation in Adolescent Pregnancies: A Cohort Study.

Leclair E, Robert N, Sprague AE, Fleming N.

J Pediatr Adolesc Gynecol. 2015 Dec;28(6):516-21. doi: 10.1016/j.jpag.2015.03.007. Epub 2015 Mar 21.

PMID:
26341744
50.

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.

Stern HM, Gardner H, Burzykowski T, Elatre W, O'Brien C, Lackner MR, Pestano GA, Santiago A, Villalobos I, Eiermann W, Pienkowski T, Martin M, Robert N, Crown J, Nuciforo P, Bee V, Mackey J, Slamon DJ, Press MF.

Clin Cancer Res. 2015 May 1;21(9):2065-74. doi: 10.1158/1078-0432.CCR-14-2993. Epub 2015 Feb 3.

Supplemental Content

Loading ...
Support Center